High Content Screening Program adopted at the National Center for Drug Screening in China
Collaboration to expand HCS technology throughout China underway
07-Sep-2004 -
The National Center for Drug Screening
(NCDS) located in Shanghai, China and Cellomics, Inc. of Pittsburgh, Pennsylvania, U.S.A
today announced a joint collaboration aimed at expanding the application of High Content
Screening (HCS) in China. Affiliated with the Shanghai Institute of Materia ...
bases
biotechnology
cell-based assays
+2